Announcement on Voluntary Disclosure of Completing the 1st Administration of ICP-332 in Patients in the United States

About this update from Innocare Pharma Ltd. Class A

Announcement on Voluntary Disclosure of Completing the 1st Administration of ICP-332 in Patients in the United States The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Innocare Pharma Ltd. Class A